Model
Edge
Seres Therapeutics
0001643766
Filing Type
4
Filing Date
6/23/2022
Updated
6/24/22, 10:31 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership